bibw 2948 bs
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2005 (NCT02214901)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bibw 2948 bs
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00726479 | Phase 2 | Aug 1, 2008 | Boehringer Ingelheim |
| NCT00423137 | Phase 2 | Jan 1, 2007 | Boehringer Ingelheim |
| NCT02216461 | Phase 1 | Jan 1, 2006 | Boehringer Ingelheim |
| NCT02214901 | Phase 1 | Mar 1, 2005 | Boehringer Ingelheim |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 4 | 4 | 2 | 2005 |
1 organizations
Page 1 / 1